In comparison to aggressive rat tumors, the number of HO-1 expressing cells at the tumor-invasive zone was found to be low in most prostate cancer patients–and HO-1 mRNA levels were low in primary prostate tumors and in adjacent non-malignant prostate tissue. This evidence concerns the gene HMOX1 and prostate cancer.